Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • fizrwinnr11 fizrwinnr11 Dec 15, 2012 9:37 PM Flag

    How the big pharmas are performing

    01) Up 28.6%. SNY (#06 in 2011, #10 in 2010)

    02) Up 16.4%. PFE (#02 in 2011, #06 in 2010)
    03) Up 16.2%. ABT (#04 in 2011, #09 in 2010)
    04) Up 15.5%. MRK (#08 in 2011, #03 in 2010)
    05) Up 15.0%. LLY (#03 in 2011, #05 in 2010)

    06) Up 10.5%. NVS (#10 in 2011, #01 in 2010)
    07) Up 07.8%. JNJ (#07 in 2011, #07 in 2010)

    08) Up 02.5%. AZN (#09 in 2011, #04 in 2010)
    09) Dn 03.3%. GSK (#05 in 2011, #08 in 2010)
    10) Dn 07.1%. BMY (#01 in 2011, #02 in 2010)

    Up 10.2%. Avg. of the ten big pharmas
    Up 09.5%. Avg. of PFE's nine big peers
    Up 10.6%. Avg. of the six domestic pharmas
    Up 09.5%. Avg. of PFE's five domestic peers
    Up 09.6%. Avg. of the four European pharmas

    Up 12.4%. S & P 500 (1,258 to 1,414)
    Up 07.5%. Dow 30 (12,218 to 13,135)

    Note: PFE is up from #05 two weeks ago and #04 last week. It is PFE's highest ranking of the year.

    Note: The difference between domestic pharmas and European pharmas has narrowed tremendously the last two month. On Oct. 19, there was a 7.8% positive difference between the domestics and the Europeans; now the difference is a mere 1%. For the first time in 2012, the Europeans are actually outperforming on balance PFE's five domestic peers.

    Sentiment: Buy

 
PFE
31.36-0.86(-2.67%)Sep 1 4:02 PMEDT